These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25427213)

  • 1. Discovery of a low order drug-cell response surface for applications in personalized medicine.
    Ding X; Liu W; Weiss A; Li Y; Wong I; Griffioen AW; van den Bergh H; Xu H; Nowak-Sliwinska P; Ho CM
    Phys Biol; 2014 Nov; 11(6):065003. PubMed ID: 25427213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A challenging drug development process in the era of personalized medicine.
    Jørgensen JT
    Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug dosage individualization based on a random-effects linear model.
    Diaz FJ; Cogollo MR; Spina E; Santoro V; Rendon DM; de Leon J
    J Biopharm Stat; 2012; 22(3):463-84. PubMed ID: 22416835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of drug combinations using Feedback System Control.
    Nowak-Sliwinska P; Weiss A; Ding X; Dyson PJ; van den Bergh H; Griffioen AW; Ho CM
    Nat Protoc; 2016 Feb; 11(2):302-15. PubMed ID: 26766116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
    Arnedos M; Soria JC; Andre F; Tursz T
    Cancer Treat Rev; 2014 Dec; 40(10):1192-8. PubMed ID: 25441102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and effective variability-a criterion for dose individualization.
    Holford NH; Buclin T
    Ther Drug Monit; 2012 Oct; 34(5):565-8. PubMed ID: 22960736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network medicine: finding the links to personalized therapy.
    Chen JY; Piquette-Miller M; Smith BP
    Clin Pharmacol Ther; 2013 Dec; 94(6):613-6. PubMed ID: 24241633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue is the issue: personalized medicine for non-small cell lung cancer.
    Hirsch FR; Wynes MW; Gandara DR; Bunn PA
    Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratified medicine: a call for action.
    Jacob I; Awada AH; Payne K; Annemans L
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):277-9. PubMed ID: 23763525
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing modifications of targeted cancer therapies in patients with special needs: evidence and controversies.
    Ng T; Chan A
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):58-74. PubMed ID: 21429761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine: a personal view.
    Meyer UA
    Clin Pharmacol Ther; 2012 Mar; 91(3):373-5. PubMed ID: 22343810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.